Chronic Graft Versus Host Disease Completed Phase 2 Trials for Bortezomib (DB00188)

Also known as: Chronic Graft-Versus-Host-Disease / Chronic Graft-Versus-Host Disease / Chronic Graft vs Host Disease / CGVHD / GVHD, Chronic / Chronic Graft-vs.-Host Disease / Chronic Graft-Versus Host Disease / Chronic Graft vs. Host Disease / Chronic GVHD / Chronic GVH disease

IndicationStatusPhase
DBCOND0039599 (Chronic Graft Versus Host Disease)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00815919Bortezomib Plus Prednisone for Initial Therapy of Chronic Graft Versus Host DiseaseTreatment